News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CombiMatrix (CBMX) And irsiCaixa Foundation Expand siRNA Collaboration And Select Candidates For Preclinical Development Against HIV


10/19/2005 5:08:58 PM

Acacia Research Corporation (Nasdaq:CBMX - News; Nasdaq:ACTG - News) announced today that its CombiMatrix group and collaborator irsiCaixa have entered into a three year research, development, and licensing agreement and have chosen two siRNA candidates for downstream pre-clinical development against HIV.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES